Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stephens Crockett

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Ocular Surface|July 29, 2009
Regression to the meanGary D Novack, R Stephens Crockett
American Journal of Ophthalmology|March 30, 2010
Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)Roger Vogel, R Stephens Crockett, Neal Oden, et al.
Clinical Therapeutics|June 11, 2004
A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertensionThomas K Mundorf, Takahiro Ogawa, Hiroaki Naka, et al.
American Journal of Ophthalmology|August 10, 2007
Adherence in glaucoma: objective measurements of once-daily and adjunctive medication useAlan L Robin, Gary D Novack, David W Covert, et al.
Current Medical Research and Opinion|April 7, 2005
Timolol LA: a double-masked, active-controlled, randomized, crossover, comfort, ocular safety, and systemic bioavailability study in healthy volunteersThomas K Mundorf, Takahiro Ogawa, Noritsugu Inui, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 10, 2004
Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel studyR Michael Siatkowski, Susan Cotter, Joseph M Miller, et al.
Ophthalmology|January 5, 2005
One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopiaDonald T H Tan, Dennis S Lam, Wei Han Chua, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Ocular Surface|July 29, 2009
Regression to the meanGary D Novack, R Stephens Crockett
American Journal of Ophthalmology|March 30, 2010
Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)Roger Vogel, R Stephens Crockett, Neal Oden, et al.
Clinical Therapeutics|June 11, 2004
A 12-month, multicenter, randomized, double-masked, parallel-group comparison of timolol-LA once daily and timolol maleate ophthalmic solution twice daily in the treatment of adults with glaucoma or ocular hypertensionThomas K Mundorf, Takahiro Ogawa, Hiroaki Naka, et al.
American Journal of Ophthalmology|August 10, 2007
Adherence in glaucoma: objective measurements of once-daily and adjunctive medication useAlan L Robin, Gary D Novack, David W Covert, et al.
Current Medical Research and Opinion|April 7, 2005
Timolol LA: a double-masked, active-controlled, randomized, crossover, comfort, ocular safety, and systemic bioavailability study in healthy volunteersThomas K Mundorf, Takahiro Ogawa, Noritsugu Inui, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 10, 2004
Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel studyR Michael Siatkowski, Susan Cotter, Joseph M Miller, et al.
Ophthalmology|January 5, 2005
One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopiaDonald T H Tan, Dennis S Lam, Wei Han Chua, et al.
Pageof 1